The drugs don't work

http://www.watoday.com.au/money/investing/the-drugs-dont-work-20141030-11eagy.html

Another news article. Focus on Alchemia, but a good mention of a tip for SRX for what its worth.

TP we share the pain

Dr Brown was disappointed but undaunted, saying on Monday that Alchemia would be "conducting an in-depth review of the data to identify the possible reasons", for the drug's trial performance. But the company could now be forced to abandon her work on HA-Irinotecan in order to cut costs and concentrate on potential growth opportunities.
This failure could be a defining moment for biotech in Australia, and investors must be asking whether you can make money out of a sector which is arguably sub-scale.
This columnist  believes that one that will do well is Sirtex Medical, producer of the SIR-Spheres device which injects radiation into cancerous tumours. Its stock has more than quadrupled since we tipped it in mid-2013. Another, which we only tipped last April and has more than doubled in price is ImpediMed, the producer of a diagnostic tool.

Read more: http://www.watoday.com.au/money/investing/the-drugs-dont-work-20141030-11eagy.html#ixzz3HcBVjBYR​

​